Brief: Haemato 9-Month EBITDA Down At EUR 1.6 Million
22/11/2019 14:18
Nov 22 (Reuters) - HAEMATO AG HAEG.DE :
* IFRS THIRD-QUARTER 2019 RESULTS
* IN Q3 OF 2019 HAEMATO AG, BERLIN (ISIN: DE0006190705),
ACHIEVED
IFRS CONSOLIDATED REVENUES OF EUR 47.8 MILLION
* IN CONSIDERED PERIOD FROM JANUARY TO SEPTEMBER 2019 SALES
TOTALED EUR 141.8 MILLION (PREVIOUS YEAR: EUR 212.8 MILLION)
* 9M EBITDA AMOUNTS TO EUR 1.6 MILLION (PREVIOUS YEAR: EUR
6.4
MILLION)
* CONSIDERS Q3 RESULTS AS INDICATORS FOR POSITIVE
DEVELOPMENT IN
LAST QUARTER OF 2019
Source text for Eikon: ID:nEQbw1yxa
Further company coverage: HAEG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln